These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 18480236

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.
    Dumas EK, Nguyen ML, Cox PM, Rodgers H, Peterson JL, James JA, Farris AD.
    Vaccine; 2013 Apr 03; 31(14):1856-63. PubMed ID: 23415781
    [Abstract] [Full Text] [Related]

  • 3. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
    Nguyen ML, Crowe SR, Kurella S, Teryzan S, Cao B, Ballard JD, James JA, Farris AD.
    Infect Immun; 2009 Jan 03; 77(1):162-9. PubMed ID: 18981257
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.
    Kelly-Cirino CD, Mantis NJ.
    Infect Immun; 2009 Nov 03; 77(11):4859-67. PubMed ID: 19703971
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes.
    Nguyen ML, Terzyan S, Ballard JD, James JA, Farris AD.
    Infect Immun; 2009 Nov 03; 77(11):4714-23. PubMed ID: 19720758
    [Abstract] [Full Text] [Related]

  • 9. Protective antigen domain 4 of Bacillus anthracis as a candidate for use as vaccine for anthrax.
    Żakowska D, Graniak G, Rutyna P, Naylor K, Głowacka P, Niemcewicz M.
    Ann Agric Environ Med; 2019 Sep 19; 26(3):392-395. PubMed ID: 31559791
    [Abstract] [Full Text] [Related]

  • 10. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK, Gross T, Larabee J, Pate L, Cuthbertson H, Charlton S, Hallis B, Engler RJM, Collins LC, Spooner CE, Chen H, Ballard J, James JA, Farris AD.
    Clin Vaccine Immunol; 2017 Nov 19; 24(11):. PubMed ID: 28877928
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.
    Park YS, Lee JH, Hung CF, Wu TC, Kim TW.
    Infect Immun; 2008 May 19; 76(5):1952-9. PubMed ID: 18285494
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
    Williamson ED, Hodgson I, Walker NJ, Topping AW, Duchars MG, Mott JM, Estep J, Lebutt C, Flick-Smith HC, Jones HE, Li H, Quinn CP.
    Infect Immun; 2005 Sep 19; 73(9):5978-87. PubMed ID: 16113318
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
    Gaur R, Gupta PK, Banerjea AC, Singh Y.
    Vaccine; 2002 Jun 21; 20(21-22):2836-9. PubMed ID: 12034111
    [Abstract] [Full Text] [Related]

  • 16. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR.
    Infect Immun; 2007 Aug 21; 75(8):4020-9. PubMed ID: 17502384
    [Abstract] [Full Text] [Related]

  • 17. Mechanistic Analysis of the Effect of Deamidation on the Immunogenicity of Anthrax Protective Antigen.
    Verma A, Ngundi MM, Burns DL.
    Clin Vaccine Immunol; 2016 May 21; 23(5):396-402. PubMed ID: 26912784
    [Abstract] [Full Text] [Related]

  • 18. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N, Verma M, Thavachelvam K, Saxena N, Mankere B, Tuteja U, Hmuaka V.
    Appl Microbiol Biotechnol; 2016 Oct 21; 100(19):8439-51. PubMed ID: 27364624
    [Abstract] [Full Text] [Related]

  • 19. A heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillus anthracis protective antigen.
    Oscherwitz J, Yu F, Cease KB.
    Infect Immun; 2009 Dec 21; 77(12):5509-18. PubMed ID: 19805525
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.